Life expectancy of at least three months. Heat Biologics Protocol No. HS130 -001 A Phase I Study of HS -130 in combination with HS-110 in patients with solid tumors HS130- 001 9 of 60 Version 2.0 - 11 Feb 2020 Confidential - Entire Page 7. Patients, both females and males, of childbearing/reproductive potenti al must agree to use adequate contraception while included in the trial and for six months after the last treatment with HS -130 and/or HS - 110. 8.